Measuring endogenous 5-HT release by emission tomography: promises and pitfalls

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. / Paterson, Louise M; Tyacke, Robin J; Nutt, David J; Knudsen, Gitte M.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 30, No. 10, 01.10.2010, p. 1682-706.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Paterson, LM, Tyacke, RJ, Nutt, DJ & Knudsen, GM 2010, 'Measuring endogenous 5-HT release by emission tomography: promises and pitfalls', Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 10, pp. 1682-706. https://doi.org/10.1038/jcbfm.2010.104

APA

Paterson, L. M., Tyacke, R. J., Nutt, D. J., & Knudsen, G. M. (2010). Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. Journal of Cerebral Blood Flow and Metabolism, 30(10), 1682-706. https://doi.org/10.1038/jcbfm.2010.104

Vancouver

Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM. Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. Journal of Cerebral Blood Flow and Metabolism. 2010 Oct 1;30(10):1682-706. https://doi.org/10.1038/jcbfm.2010.104

Author

Paterson, Louise M ; Tyacke, Robin J ; Nutt, David J ; Knudsen, Gitte M. / Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. In: Journal of Cerebral Blood Flow and Metabolism. 2010 ; Vol. 30, No. 10. pp. 1682-706.

Bibtex

@article{d83fdc056d994c49b11d32b5e87aedfb,
title = "Measuring endogenous 5-HT release by emission tomography: promises and pitfalls",
abstract = "Molecular in vivo neuroimaging techniques can be used to measure regional changes in endogenous neurotransmitters, evoked by challenges that alter synaptic neurotransmitter concentration. This technique has most successfully been applied to the study of endogenous dopamine release using positron emission tomography, but has not yet been adequately extended to other neurotransmitter systems. This review focuses on how the technique has been applied to the study of the 5-hydroxytryptamine (5-HT) system. The principles behind visualising fluctuations in neurotransmitters are introduced, with reference to the dopaminergic system. Studies that aim to image acute, endogenous 5-HT release or depletion at 5-HT receptor targets are summarised, with particular attention to studies in humans. Radiotracers targeting the 5-HT(1A), 5-HT(2A), and 5-HT(4) receptors and the serotonin reuptake transporter have been explored for their sensitivity to 5-HT fluctuations, but with mixed outcomes; tracers for these targets cannot reliably image endogenous 5-HT in humans. Shortcomings in our basic knowledge of the mechanisms underlying changes in binding potential are addressed, and suggestions are made as to how the selection of targets, radiotracers, challenge paradigms, and experimental design might be optimised to improve our chances of successfully imaging endogenous neurotransmitters in the future.",
author = "Paterson, {Louise M} and Tyacke, {Robin J} and Nutt, {David J} and Knudsen, {Gitte M}",
year = "2010",
month = oct,
day = "1",
doi = "http://dx.doi.org/10.1038/jcbfm.2010.104",
language = "English",
volume = "30",
pages = "1682--706",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "SAGE Publications",
number = "10",

}

RIS

TY - JOUR

T1 - Measuring endogenous 5-HT release by emission tomography: promises and pitfalls

AU - Paterson, Louise M

AU - Tyacke, Robin J

AU - Nutt, David J

AU - Knudsen, Gitte M

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Molecular in vivo neuroimaging techniques can be used to measure regional changes in endogenous neurotransmitters, evoked by challenges that alter synaptic neurotransmitter concentration. This technique has most successfully been applied to the study of endogenous dopamine release using positron emission tomography, but has not yet been adequately extended to other neurotransmitter systems. This review focuses on how the technique has been applied to the study of the 5-hydroxytryptamine (5-HT) system. The principles behind visualising fluctuations in neurotransmitters are introduced, with reference to the dopaminergic system. Studies that aim to image acute, endogenous 5-HT release or depletion at 5-HT receptor targets are summarised, with particular attention to studies in humans. Radiotracers targeting the 5-HT(1A), 5-HT(2A), and 5-HT(4) receptors and the serotonin reuptake transporter have been explored for their sensitivity to 5-HT fluctuations, but with mixed outcomes; tracers for these targets cannot reliably image endogenous 5-HT in humans. Shortcomings in our basic knowledge of the mechanisms underlying changes in binding potential are addressed, and suggestions are made as to how the selection of targets, radiotracers, challenge paradigms, and experimental design might be optimised to improve our chances of successfully imaging endogenous neurotransmitters in the future.

AB - Molecular in vivo neuroimaging techniques can be used to measure regional changes in endogenous neurotransmitters, evoked by challenges that alter synaptic neurotransmitter concentration. This technique has most successfully been applied to the study of endogenous dopamine release using positron emission tomography, but has not yet been adequately extended to other neurotransmitter systems. This review focuses on how the technique has been applied to the study of the 5-hydroxytryptamine (5-HT) system. The principles behind visualising fluctuations in neurotransmitters are introduced, with reference to the dopaminergic system. Studies that aim to image acute, endogenous 5-HT release or depletion at 5-HT receptor targets are summarised, with particular attention to studies in humans. Radiotracers targeting the 5-HT(1A), 5-HT(2A), and 5-HT(4) receptors and the serotonin reuptake transporter have been explored for their sensitivity to 5-HT fluctuations, but with mixed outcomes; tracers for these targets cannot reliably image endogenous 5-HT in humans. Shortcomings in our basic knowledge of the mechanisms underlying changes in binding potential are addressed, and suggestions are made as to how the selection of targets, radiotracers, challenge paradigms, and experimental design might be optimised to improve our chances of successfully imaging endogenous neurotransmitters in the future.

U2 - http://dx.doi.org/10.1038/jcbfm.2010.104

DO - http://dx.doi.org/10.1038/jcbfm.2010.104

M3 - Journal article

VL - 30

SP - 1682

EP - 1706

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 10

ER -

ID: 34142962